| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 11/19/2008 | CN101305777A Gingko pulp paste |
| 11/19/2008 | CN101305766A Active yam protein powder and its production method |
| 11/19/2008 | CN101305758A Broussonetia papyrifera leaves tea and its preparation method |
| 11/19/2008 | CN100434420C Compound inhibiting dipeptidyl peptidase iv |
| 11/19/2008 | CN100434099C Medicinal composition for diabete and its making method |
| 11/19/2008 | CN100434091C Fenugreek seed extract and its preparing process and application |
| 11/19/2008 | CN100434071C Use of indole-2,3-dione for preparing medicine for cardio-cerehral vascular disease |
| 11/19/2008 | CN100434069C Stable compositions of atorvastatin prepared with wet granulation |
| 11/18/2008 | US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing |
| 11/18/2008 | US7452966 GLP-1 analog fusion proteins |
| 11/18/2008 | US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/18/2008 | US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 11/18/2008 | US7452905 Phenylalanine derivatives |
| 11/18/2008 | US7452898 Use of 1-O-octadecylpropanediol-3-cidofovir to treat viral diseases such as HIV, influenza, herpes virus, cytomegalovirus, hepatitis virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus |
| 11/18/2008 | US7452897 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 11/18/2008 | US7452891 MCH antagonists and their use in the treatment of obesity |
| 11/18/2008 | US7452888 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders |
| 11/18/2008 | US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 11/18/2008 | US7452882 Thyroid hormone analogs |
| 11/18/2008 | US7452873 Inhibitors of GSK-3 and uses thereof |
| 11/18/2008 | US7452860 Zinc-free and low-zinc insulin preparations having improved stability |
| 11/18/2008 | US7452858 Administering exendin, or an antagonist thereof; reducing blood glucose concentration |
| 11/18/2008 | CA2457070C A method for processing tea flower |
| 11/18/2008 | CA2455539C Pig growth enhancer and pig growth enhancing method |
| 11/18/2008 | CA2440222C Triazolopyridines as anti-inflammatory agents |
| 11/18/2008 | CA2434682C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 11/18/2008 | CA2422379C Pyrazole compounds useful as protein kinase inhibitors |
| 11/18/2008 | CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 11/18/2008 | CA2362281C Combinations for the treatment of diseases involving angiogenesis |
| 11/18/2008 | CA2352430C New pharmaceutical composition and the process for its preparation |
| 11/18/2008 | CA2343116C Methods and compositions for increasing intestinal absorption of fats |
| 11/18/2008 | CA2320822C Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 11/18/2008 | CA2318184C Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative as selective endothelin antagonists |
| 11/18/2008 | CA2316298C Fat blend |
| 11/18/2008 | CA2305802C Amide derivatives or salts thereof |
| 11/18/2008 | CA2296725C Polyhydroxybutylpyrazines, their preparation and medicines containing them |
| 11/18/2008 | CA2205112C Method and composition for treating mammalian diseases caused by inflammatory response |
| 11/18/2008 | CA2143752C Method of preventing nmda receptor-mediated neuronal damage |
| 11/18/2008 | CA1341585C Recombinant retroviruses |
| 11/13/2008 | WO2008137633A2 Methods of modulating cellular homeostatic pathways and cellular survival |
| 11/13/2008 | WO2008137436A1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| 11/13/2008 | WO2008137435A1 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 11/13/2008 | WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity |
| 11/13/2008 | WO2008136547A1 Method of preventing or treating body weight disorders by employing clusterin |
| 11/13/2008 | WO2008136511A1 Therapeutic agent for diabetic neuropathy |
| 11/13/2008 | WO2008136444A1 Fused heterocyclic derivative |
| 11/13/2008 | WO2008136428A1 Nitrogen-containing five-membered heterocyclic compound |
| 11/13/2008 | WO2008136393A1 Crystal of lactam compound, and method for production thereof |
| 11/13/2008 | WO2008136392A1 Preparation for oral administration |
| 11/13/2008 | WO2008136382A1 Bicyclic compound and pharmaceutical use thereof |
| 11/13/2008 | WO2008136331A1 BRANCHED α-GLUCAN, α-GLUCOSYLTRANSFERASE PRODUCING THE SAME, METHOD FOR PRODUCING THE SAME AND USE THEREOF |
| 11/13/2008 | WO2008136173A1 Adipocyte differentiation inhibitor containing stilbene derivative as active ingredient |
| 11/13/2008 | WO2008136013A1 An organoleptically enhanced salacia plant extract and a process thereof (minora) |
| 11/13/2008 | WO2008135984A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 11/13/2008 | WO2008135522A1 Use of s1p receptor modulator |
| 11/13/2008 | WO2008135239A1 PHARMACEUTICAL COMPOSITION FOR INCREASING INSULIN SECRETION FROM PANCREATIC β-CELLS |
| 11/13/2008 | WO2008118718A3 2-aminopyridine analogs as glucokinase activators |
| 11/13/2008 | WO2008115098A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof |
| 11/13/2008 | WO2008099072A3 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 11/13/2008 | WO2008083678A3 Pharmaceutically active compounds |
| 11/13/2008 | WO2007056279A3 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors |
| 11/13/2008 | US20080281092 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 11/13/2008 | US20080280994 Brown seaweed that has pharmacological properties ; glucosidase inhibitor; reducing blood glucose concentration; antidiabetic agents; obesity; free radical scavenger; activation macrophages; moderating nitric acid production |
| 11/13/2008 | US20080280985 Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes |
| 11/13/2008 | US20080280982 3-{4-[1-(4'-tert-Butyl-biphenyl-4-ylmethyl)-3-methyl-butyl]-benzoylamino}-propionic acid, used as hypoglycemic agents of for the treatment of metabolic disorders such as diabetes |
| 11/13/2008 | US20080280979 Methods and Compositions of Derivatives of Probucol for the Treatment of Diabetes |
| 11/13/2008 | US20080280976 Composition Comprising the Alcohol Compound Isolated from the Extract of Cucurbitaceae Family Plant Having Anti-Adipogenic and Anti-Obesity Activity |
| 11/13/2008 | US20080280959 Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof |
| 11/13/2008 | US20080280942 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands |
| 11/13/2008 | US20080280931 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| 11/13/2008 | US20080280922 Drug mixture containing apoliprotein and mitrosomal triglyceride transfer protrein inhibitor; veterinary medicine |
| 11/13/2008 | US20080280913 dipeptidyl-peptidase IV (DPP-IV) inhibitors such as 5,5,6,6,8,8-d6-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine; increasing hormone glucagon-like peptide levels; pharmacokinetics; side effect reduction |
| 11/13/2008 | US20080280909 New phenylalanine derivatives |
| 11/13/2008 | US20080280904 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors |
| 11/13/2008 | US20080280887 Selected Cgrp-Antagonists, Processes for Preparing Them and Their Use as Pharmaceutical Compositions |
| 11/13/2008 | US20080280875 Fused phenyl amido heterocyclic compounds |
| 11/13/2008 | US20080280874 Phenoxy Benzamide Compounds with Utility in the Treatment of Type 2 Diabetes and Obesity |
| 11/13/2008 | US20080280872 Benzamide Derivatives and Their Use as Glucokinase Activating Agents |
| 11/13/2008 | US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus |
| 11/13/2008 | US20080280852 Composition Containing Fermentable Polysaccharides |
| 11/13/2008 | US20080280845 an antisense compound that hybridizes with a nucleic acid molecule that expreses PTPRU ( protein tyrosine phosphatase receptor type U), thereby inhibiting the expression of the nucleic acid molecule; treatment of diabetes, obesity, insulin resistance, insulin deficiency, hypercholesterolemia etc. |
| 11/13/2008 | US20080280836 novel cholesterol absorption inhibitors; 1-phenyl-2-(p-benzylphenyl)-3-substituted azetidin-4-ones |
| 11/13/2008 | US20080280820 Novel Peptides for Use in the Treatment of Obesity |
| 11/13/2008 | US20080280815 Lowering Serum Lipids |
| 11/13/2008 | US20080280814 Pharmaceutical Compositions Containing Insulin and Insulinotropic Peptide |
| 11/13/2008 | US20080280308 G protein coupled receptor signaling modulation |
| 11/13/2008 | US20080279969 Composition Comprising Bamboo Extract for Androgen Agonist |
| 11/13/2008 | US20080279968 Composition and method for inducing lipolysis and increasing the metabolism of free fatty acids |
| 11/13/2008 | US20080279967 Composition and method for increasing the metabolism of free fatty acids and facilitating a favorable blood lipid |
| 11/13/2008 | US20080279934 Multilayer tablet ; autoimmune disease; antidiabetic agents; rheumatic disorders; antiarthritic agents; psoriasis |
| 11/13/2008 | US20080279932 Vildagliptin salt; in mixture with therapeutic agents such as antidiabetic agents; antilipemic agents; obesity; appetite control; hypotensive agents; cholesterol absorption moderators; anticoagulants; estrogen receptor moderators; transferring across blood-brain barrier |
| 11/13/2008 | US20080279897 Method of Treating Cellular Damage |
| 11/13/2008 | US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells |
| 11/13/2008 | US20080279866 Treating lymphomas, allergies and autoimmune diseases via apoptotic induction; using ATP-competitive inhibitor, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU-55933) and lymphocyte specific immunoglobulins |
| 11/13/2008 | US20080279864 High Throughput Screen Utilizing Newly Discovered Intramolecular Neuronal Calcium Channel Interactions To Discover New Analgesics |
| 11/13/2008 | US20080279857 Therapeutic Agent |
| 11/13/2008 | US20080279852 Methods of treatment with glycosylated antibodies |
| 11/13/2008 | US20080279843 Using concentration of inflammation marker protein as evaluative signal for enzyme inhibitor dispension; drug delivery and antidiabetic agents |
| 11/13/2008 | US20080279839 Composition With a Fungal (Yeast) Lipase and Method For Treating Lipid Malabsorption in Cystic Fibrous as Well as People Suffering From Pancreatic Lipase Insufficiency |
| 11/13/2008 | US20080279827 Preparation and xenotransplantation of porcine islets |